Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon identifies several related series of antiglaucoma agents

Nov. 22, 2001

Positive opinion issued for Lumigan by CPMP

Nov. 21, 2001

Launch of Xalcom/Xalacom begins in Europe

Nov. 20, 2001

Six-month results presented for CAT-152 following glaucoma and cataract surgery

Nov. 16, 2001

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Indian research institute evaluates andrographolide derivatives

Sep. 21, 2001

Enrollment of patients completed for phase III INS-365 Ophthalmic clinical program

Sep. 19, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...